July 23, 2019
|Duration||1 semester (14 teaching weeks)|
|Level||Year 3, Semester 6|
|Unit Weighting||Unit Credit Points: 10 credit points
Total Course Credit Points: 320 credit points
|Student Workload||Number of timetabled hours per week: 9 (including 5 hours clinical practice)
Number of personal study hours per week: 1
Total workload hours per week: 10
|Prerequisites/ Corequisites||CCM303 TCM Internal Medicine; CCM304 TCM Traumatology|
|Description||This unit includes two parts: Wen Bing Xue and TCM Practice 3 (Herbal Dispensary).
The first part of Wen Bing Xue introduces students to the classical texts of Wen Bing Xue (Studies of Diseases Due to Warm Pathogens).
Students study the philosophy and theory of Wen Bing Xue which provides students with a comprehensive understanding of the diagnosis and treatment of febrile diseases. Students acquire an overview of the historical development of the Wen Bing theories, contribution to CM treatment framework, contraindication and cautions, strengthens and limitations. The focus of study is on the characteristics of the four phases (Wei; Qi; Ying; and Xue) and the San Jiao classifications of febrile diseases and the diagnostic and treatment methods used in the management of Wen Bing (febrile diseases). The treatment of specific Wen Bing diseases including their aetiology, differentiation of symptoms, treatment principles and formulae is also included.
The second part of TCM Practice 3 (Herbal Dispensary) is focused on dispensing prescriptions and the aims of Paozhi and relevant techniques; Students will acquire specific knowledge of the theories that underpin and enable the safe application of Chinese herbal dispensing skills, including ethical and legal issues, policy and guidelines, botany, taxonomy and zoology, basic herbal processing, interaction between herbal and pharmaceutical medicines. The focus will be on performing the duties of a dispenser in an active clinic and Paozhi lab. In a supervised dispensary, students should undertake all aspects of management including the preparation and processing of herbs and the dispensing of prescriptions. In the Paozhi lab, students should practice all Paozhi techniques in related to their individuate requirements throughout the study of this subject and in accordance with Australian regulations and the SUSMP. The importance of a commitment to appropriate reporting of adverse events and implementation of appropriate first aid measures when a patient displays an adverse reaction to treatment, and ensure prompt transfer to medical services where necessary will be emphasized. Appreciation of Australia’s healthcare context and the multi-cultural/multi-racial nature of the community and how this may affect the practice of TCM will be discussed and debated. The desire to achieve excellence in the practice of Chinese herbal medicine and to contribute to improving both the quality of life of patients and the wellbeing of the community and the environment will be a key feature in the teaching and learning of this unit.
For clinical practice, students will be provided with the opportunity of reporting and reflecting on their observations in the clinic and gain experience in acupuncture, herbal medicine treatment, and herbal dispensary.
Students will be referred constantly and appropriately throughout the course to the TGA and CMBA guidelines on the use of herbs vis-à-vis the various regulatory instruments and the management and reporting of adverse events.
|Learning outcomes||Upon completion of this unit students should be able to:
|Unit requirement||To successfully complete the unit, students must: attend 80% of all the lectures and tutorial classes plus 100% of clinic hours including fulfilling all rostered receptionist duties; attempt all assessment tasks including summative and formative assessments and achieve at least 50% of the total marks; and achieve a mark of at least 40% in the final examination and at least 50% in Clinical Assessment.|
|Assessment||Assessment 1: Case Study Analysis (Wen Bing) 25%
Assessment 2: Practical Test (Herbal Dispensary) 15%
Assessment 3: Clinical Assessment 20%
Assessment 4: Final Examination 40%
|Prescribed text||Liu, G. (2005). Warm pathogen diseases: A clinical guide (Revised ed.). Seattle: Eastland Press.
Bensky, D., Clavey, S., Gamble, A., &Stoger, E. (2004). Chinese herbal medicine: Materia medica (3rd ed.). Seattle, Wash.: Eastland Press.
Bensky, D., &Barolet, R. (2009). In Scheid V. (Ed.), Chinese herbal medicine: Formulas & strategies (Rev. ed.). Seattle, WA: Eastland Press.
|Recommended readings||Wen, J. M., & Seifert, G. (2000). Warm disease theory – wen bingxue. Brooklyn, Mass.: Paradigm.
Sydney Institute of Traditional Chinese Medicine (2015). Australian Regulations on Restricted Chinese Herbal Medicine
Cai, Bao Chang (2008): Processing of Chinese Materia Medica. Beijing, China Chinese Medicine Press.
Chang, H., & But, P. P. H. (1986). (1986). Pharmacology and applications of Chinese material medica (English ed.). Singapore; Philadelphia, PA, USA: World Scientific.
Chinese Medicine Board of Australia (2015), Guidelines for safe Chinese herbal medicine practice, Available at https://www.chinesemedicineboard.gov.au/Codes-Guidelines/Guidelines-for-safe-practice.aspx (Accessed 07/01/2019)
Kerridge, I. H., Lowe, M., & Stewart, C. (2009). Ethics and law for the health professions (3rd ed.). Annandale, N.S.W.: The Federation Press.
Maciocia, G. (2008). The practice of Chinese medicine: The treatment of diseases with acupuncture and Chinese herbs (2nd ed.). Edinburgh; New York: Elsevier.
National Drugs and Poisons Schedule Committee (NDPSC). (2018). Standard for the uniform scheduling of Medicines and poisons. Canberra: Australian Government. Available at https://www.tga.gov.au/scheduling-medicines-poisons (Accessed 07/01/2019)
Weir, M. (2007). Complementary medicine: Ethics and law (3rd ed.). Ashgrove, Qld. Prometheus Publications.
Advisory Committees on Medicines (2018). Australian regulatory guidelines for complementary medicines. https://www.tga.gov.au/publication/australian-regulatory-guidelines-complementary-medicines-argcm (Accessed 07/01/2019)
TGA (2018). Updated to the Permissible Ingredient Determination for listed medicines. https://www.tga.gov.au/updates-permissible-ingredients-determination-listed-medicines (Accessed 07/01/2019)